Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156882322> ?p ?o ?g. }
- W2156882322 endingPage "127" @default.
- W2156882322 startingPage "123" @default.
- W2156882322 abstract "Allogeneic bone marrow transplantation (BMT) is a therapeutic modality with a curative potential for chronic granulocytic leukemia. Approximately 20% of patients have a hematologic relapse after BMT. The frequency of cytogenetic or molecular relapse (or both), despite hematologic remission, is reportedly higher. We performed allogeneic BMT in 32 patients with chronic granulocytic leukemia by using unmanipulated donor marrow and a conditioning regimen that consisted of cyclophosphamide and total-body irradiation. Of these 32 patients, 23 had cytogenetic studies after BMT. Seven of these patients had cytogenetically detectable Philadelphia chromosomes some time after BMT, during hematologic remission. The Philadelphia chromosome was detected transiently in two patients, and the fraction of abnormal metaphases exceeded 25% in three patients. None of the patients with negative results of cytogenetic studies or with the presence of the Philadelphia chromosome in less than 25% of analyzed metaphases had a clinical relapse, whereas two of the three patients with more than 25% abnormal metaphases had clinical relapses. Our results suggest that the detection of more than 25% abnormal metaphases during cytogenetic studies for chronic granulocytic leukemia after BMT may imply an incipient clinical relapse. We review the current literature that discusses isolated cytogenetic or molecular relapses of chronic granulocytic leukemia after BMT. Allogeneic bone marrow transplantation (BMT) is a therapeutic modality with a curative potential for chronic granulocytic leukemia. Approximately 20% of patients have a hematologic relapse after BMT. The frequency of cytogenetic or molecular relapse (or both), despite hematologic remission, is reportedly higher. We performed allogeneic BMT in 32 patients with chronic granulocytic leukemia by using unmanipulated donor marrow and a conditioning regimen that consisted of cyclophosphamide and total-body irradiation. Of these 32 patients, 23 had cytogenetic studies after BMT. Seven of these patients had cytogenetically detectable Philadelphia chromosomes some time after BMT, during hematologic remission. The Philadelphia chromosome was detected transiently in two patients, and the fraction of abnormal metaphases exceeded 25% in three patients. None of the patients with negative results of cytogenetic studies or with the presence of the Philadelphia chromosome in less than 25% of analyzed metaphases had a clinical relapse, whereas two of the three patients with more than 25% abnormal metaphases had clinical relapses. Our results suggest that the detection of more than 25% abnormal metaphases during cytogenetic studies for chronic granulocytic leukemia after BMT may imply an incipient clinical relapse. We review the current literature that discusses isolated cytogenetic or molecular relapses of chronic granulocytic leukemia after BMT." @default.
- W2156882322 created "2016-06-24" @default.
- W2156882322 creator A5016216479 @default.
- W2156882322 creator A5018112409 @default.
- W2156882322 creator A5055648300 @default.
- W2156882322 creator A5071977576 @default.
- W2156882322 creator A5082624440 @default.
- W2156882322 creator A5090561132 @default.
- W2156882322 date "1992-02-01" @default.
- W2156882322 modified "2023-09-25" @default.
- W2156882322 title "Cytogenetic and Molecular Detection of Residual Leukemic Cells After Allogeneic Bone Marrow Transplantation in Chronic Granulocytic Leukemia" @default.
- W2156882322 cites W1652033010 @default.
- W2156882322 cites W1983293449 @default.
- W2156882322 cites W1986680315 @default.
- W2156882322 cites W19910863 @default.
- W2156882322 cites W1997180860 @default.
- W2156882322 cites W2027302362 @default.
- W2156882322 cites W2057343017 @default.
- W2156882322 cites W2082235401 @default.
- W2156882322 cites W2122455557 @default.
- W2156882322 cites W2397280904 @default.
- W2156882322 cites W2402529725 @default.
- W2156882322 cites W2409866738 @default.
- W2156882322 cites W2429410018 @default.
- W2156882322 cites W68935899 @default.
- W2156882322 cites W3145999354 @default.
- W2156882322 doi "https://doi.org/10.1016/s0025-6196(12)61311-1" @default.
- W2156882322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1545574" @default.
- W2156882322 hasPublicationYear "1992" @default.
- W2156882322 type Work @default.
- W2156882322 sameAs 2156882322 @default.
- W2156882322 citedByCount "4" @default.
- W2156882322 crossrefType "journal-article" @default.
- W2156882322 hasAuthorship W2156882322A5016216479 @default.
- W2156882322 hasAuthorship W2156882322A5018112409 @default.
- W2156882322 hasAuthorship W2156882322A5055648300 @default.
- W2156882322 hasAuthorship W2156882322A5071977576 @default.
- W2156882322 hasAuthorship W2156882322A5082624440 @default.
- W2156882322 hasAuthorship W2156882322A5090561132 @default.
- W2156882322 hasConcept C104317684 @default.
- W2156882322 hasConcept C126322002 @default.
- W2156882322 hasConcept C138626823 @default.
- W2156882322 hasConcept C142724271 @default.
- W2156882322 hasConcept C174475383 @default.
- W2156882322 hasConcept C203014093 @default.
- W2156882322 hasConcept C2776694085 @default.
- W2156882322 hasConcept C2776755627 @default.
- W2156882322 hasConcept C2776863199 @default.
- W2156882322 hasConcept C2778461978 @default.
- W2156882322 hasConcept C2778880498 @default.
- W2156882322 hasConcept C2778904597 @default.
- W2156882322 hasConcept C2780007613 @default.
- W2156882322 hasConcept C2781071720 @default.
- W2156882322 hasConcept C2910168157 @default.
- W2156882322 hasConcept C2911091166 @default.
- W2156882322 hasConcept C30481170 @default.
- W2156882322 hasConcept C55493867 @default.
- W2156882322 hasConcept C71924100 @default.
- W2156882322 hasConcept C86803240 @default.
- W2156882322 hasConcept C90924648 @default.
- W2156882322 hasConceptScore W2156882322C104317684 @default.
- W2156882322 hasConceptScore W2156882322C126322002 @default.
- W2156882322 hasConceptScore W2156882322C138626823 @default.
- W2156882322 hasConceptScore W2156882322C142724271 @default.
- W2156882322 hasConceptScore W2156882322C174475383 @default.
- W2156882322 hasConceptScore W2156882322C203014093 @default.
- W2156882322 hasConceptScore W2156882322C2776694085 @default.
- W2156882322 hasConceptScore W2156882322C2776755627 @default.
- W2156882322 hasConceptScore W2156882322C2776863199 @default.
- W2156882322 hasConceptScore W2156882322C2778461978 @default.
- W2156882322 hasConceptScore W2156882322C2778880498 @default.
- W2156882322 hasConceptScore W2156882322C2778904597 @default.
- W2156882322 hasConceptScore W2156882322C2780007613 @default.
- W2156882322 hasConceptScore W2156882322C2781071720 @default.
- W2156882322 hasConceptScore W2156882322C2910168157 @default.
- W2156882322 hasConceptScore W2156882322C2911091166 @default.
- W2156882322 hasConceptScore W2156882322C30481170 @default.
- W2156882322 hasConceptScore W2156882322C55493867 @default.
- W2156882322 hasConceptScore W2156882322C71924100 @default.
- W2156882322 hasConceptScore W2156882322C86803240 @default.
- W2156882322 hasConceptScore W2156882322C90924648 @default.
- W2156882322 hasIssue "2" @default.
- W2156882322 hasLocation W21568823221 @default.
- W2156882322 hasLocation W21568823222 @default.
- W2156882322 hasOpenAccess W2156882322 @default.
- W2156882322 hasPrimaryLocation W21568823221 @default.
- W2156882322 hasRelatedWork W2007979338 @default.
- W2156882322 hasRelatedWork W2011102229 @default.
- W2156882322 hasRelatedWork W2156882322 @default.
- W2156882322 hasRelatedWork W2279034678 @default.
- W2156882322 hasRelatedWork W2401867714 @default.
- W2156882322 hasRelatedWork W2410941464 @default.
- W2156882322 hasRelatedWork W2415083499 @default.
- W2156882322 hasRelatedWork W2422991312 @default.
- W2156882322 hasRelatedWork W2463666452 @default.
- W2156882322 hasRelatedWork W4247513461 @default.
- W2156882322 hasVolume "67" @default.
- W2156882322 isParatext "false" @default.